Ritholtz Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Ritholtz Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.21M	Sell	13,306 -6,422	-33%	-$1.41M	0.05%	297
2026 Q1	$3.73M	Sell	19,728 -1,886	-9%	-$330K	0.06%	227
2025 Q4	$3.67M	Buy	21,614 +1,144	+6%	+$175K	0.07%	211
2025 Q3	$2.7M	Buy	20,470 +3,937	+24%	+$472K	0.05%	252
2025 Q2	$1.75M	Buy	16,533 +1,237	+8%	+$134K	0.04%	327
2025 Q1	$1.9M	Buy	+15,296	New	+$2M	0.06%	259

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Ritholtz Wealth Management's JAZZ Position: Q2 2026 in Review

Ritholtz Wealth Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 33% in Q2 2026, selling an estimated $1.41M and leaving 13,306 shares worth $3.21M. The position accounts for 0.05% of the portfolio, ranked #297.

Ritholtz Wealth Management first reported a position in JAZZ in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.73M in Q1 2026. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Ritholtz Wealth Management held 13,306 shares of Jazz Pharmaceuticals worth $3.21M as of Q2 2026.
Ritholtz Wealth Management sold 6,422 Jazz Pharmaceuticals shares in Q2 2026, an estimated $1.41M.
Jazz Pharmaceuticals made up 0.05% of Ritholtz Wealth Management's portfolio in Q2 2026, its #297 holding.
Ritholtz Wealth Management first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
Ritholtz Wealth Management's Jazz Pharmaceuticals position peaked at $3.73M in Q1 2026.
646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Ritholtz Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.